| scholarly article | Q13442814 |
| P2093 | author name string | W H Wilson Tang | |
| Stanley L Hazen | |||
| Yuping Wu | |||
| Matthias Dupont | |||
| P2860 | cites work | Association of cystatin C with mortality, cardiovascular events, and incident heart failure among persons with coronary heart disease: data from the Heart and Soul Study | Q24646339 |
| Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD | Q24652643 | ||
| Cystatin C and the risk of death and cardiovascular events among elderly persons | Q28251528 | ||
| Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement | Q28256758 | ||
| Comparative performance of the CKD Epidemiology Collaboration (CKD-EPI) and the Modification of Diet in Renal Disease (MDRD) Study equations for estimating GFR levels above 60 mL/min/1.73 m2. | Q34079762 | ||
| Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Preventi | Q34272627 | ||
| Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate | Q34557258 | ||
| Cystatin C: an improved estimator of glomerular filtration rate? | Q34616081 | ||
| Plasma concentration of amino-terminal pro-brain natriuretic peptide in chronic heart failure: prediction of cardiovascular events and interaction with the effects of rosuvastatin: a report from CORONA (Controlled Rosuvastatin Multinational Trial in | Q35011439 | ||
| Measurement of kidney function | Q36065308 | ||
| Method of glomerular filtration rate estimation affects prediction of mortality risk | Q37367733 | ||
| Cystatin-C and mortality in elderly persons with heart failure. | Q40454237 | ||
| Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms | Q44272913 | ||
| The comparative prognostic value of plasma neurohormones at baseline in patients with heart failure enrolled in Val-HeFT. | Q44777037 | ||
| Performance of the modification of diet in renal disease and Cockcroft-Gault equations in the estimation of GFR in health and in chronic kidney disease | Q45198991 | ||
| Usefulness of cystatin C and prognosis following admission for acute heart failure. | Q45925790 | ||
| Complementary prognostic value of cystatin C, N-terminal pro-B-type natriuretic Peptide and cardiac troponin T in patients with acute heart failure. | Q45962783 | ||
| Cystatin C in acute heart failure without advanced renal impairment. | Q46037179 | ||
| Cystatin C, a novel measure of renal function, is an independent predictor of cardiac events in patients with heart failure | Q46757357 | ||
| Prognostic value of cystatin C in acute heart failure in relation to other markers of renal function and NT-proBNP. | Q48278579 | ||
| Cystatin C and estimates of renal function: searching for a better measure of kidney function in diabetic patients. | Q51924362 | ||
| Drawbacks and prognostic value of formulas estimating renal function in patients with chronic heart failure and systolic dysfunction. | Q51932219 | ||
| Renal function, neurohormonal activation, and survival in patients with chronic heart failure. | Q52076638 | ||
| The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction. | Q52081068 | ||
| Use of cystatin C levels in estimating renal function and prognosis in patients with chronic systolic heart failure. | Q53090641 | ||
| Serum cystatin C as a new marker for noninvasive estimation of glomerular filtration rate and as a marker for early renal impairment | Q73938868 | ||
| Serum cystatin C predicts progression of subclinical coronary atherosclerosis in individuals with type 1 diabetes | Q80693146 | ||
| Impact of myocardial function on cystatin C measurements in chronic systolic heart failure | Q81365999 | ||
| P433 | issue | 5 | |
| P921 | main subject | heart failure | Q181754 |
| chronic heart failure | Q11829287 | ||
| P304 | page(s) | 602-609 | |
| P577 | publication date | 2012-08-16 | |
| P1433 | published in | Circulation: Heart Failure | Q2865806 |
| P1476 | title | Cystatin C identifies patients with stable chronic heart failure at increased risk for adverse cardiovascular events | |
| P478 | volume | 5 |
| Q57070928 | Association Between Increased Levels of Cystatin C and the Development of Cardiovascular Events or Mortality: A Systematic Review and Meta-Analysis |
| Q37670965 | Association between high cystatin C levels and carotid atherosclerosis |
| Q53306249 | Association of serum cystatin C levels with myocardial perfusion and cardiac functional recovery in patients with anterior wall ST elevation myocardial infarction treated with primary coronary intervention. |
| Q47216784 | Biochemical and Clinical Impact of Organic Uremic Retention Solutes: A Comprehensive Update |
| Q38859863 | Chronic Heart Failure and Comorbid Renal Dysfunction - A Focus on Type 2 Cardiorenal Syndrome |
| Q38152289 | Circulating biomarkers in patients with heart failure and preserved ejection fraction |
| Q38588158 | Clinical management of patients with acute heart failure |
| Q36265357 | Correlations of serum cystatin C and glomerular filtration rate with vascular lesions and severity in acute coronary syndrome |
| Q37251866 | Cross-sectional study on the relationship between the level of serum cystatin C and blood pressure reverse dipping in hypertensive patients. |
| Q37347009 | Incorporating common biomarkers into the clinical management of heart failure |
| Q36479634 | Incremental value of cystatin C over conventional renal metrics for predicting clinical response and outcomes in cardiac resynchronization therapy: The BIOCRT study |
| Q38252731 | Novel renal biomarkers to assess cardiorenal syndrome |
| Q41993082 | Prognostic importance of emerging cardiac, inflammatory, and renal biomarkers in chronic heart failure patients with reduced ejection fraction and anaemia: RED-HF study. |
| Q35091397 | Relation of baseline plasma MMP-1 levels to long-term all-cause mortality in patients with known or suspected coronary artery disease referred for coronary angiography. |
| Q40998882 | Serum Cystatin C and the Risk of Coronary Heart Disease in Ethnic Chinese Patients With Normal Renal Function |
| Q37229937 | Serum cystatin C concentration as an independent marker for hypertensive left ventricular hypertrophy |
| Q41818342 | The Change in Body Weight During Hospitalization Predicts Mortality in Patients With Acute Decompensated Heart Failure |
| Q27011043 | The kidney in congestive heart failure: 'are natriuresis, sodium, and diuretics really the good, the bad and the ugly?' |
| Q48586571 | The potential of cystatin-C to evaluate the prognosis of acute heart failure: A comparative study |
Search more.